文献速递中毒与环境急症消化、代谢与肾脏急症

利用尿液药物检测数据及时估算美国药物过量死亡人数

Generating Timely Estimates of Overdose Deaths for the US Using Urine Drug Test Data.
PubMed 文献 · JAMA Netw Open · 2025-06-02
一句话结论横断面研究提示,聚合尿液药物检测数据结合负二项广义线性模型可估算官方数据滞后6个月窗口内的全国药物过量死亡数,误差低于基线模型。

本研究纳入2015年1月1日至2025年1月31日美国物质使用障碍治疗机构提交的3135748份尿液药物检测样本,聚合为月度阳性率和芬太尼、甲基苯丙胺肌酐归一化均值。以负二项分布广义线性模型基于前4年数据训练,估算2019年1–6月至2024年8月–2025年1月每个6个月滞后窗口的药物过量死亡总数,并与CDC观察值比较。结果模型平均绝对百分比误差7.1%、平均绝对误差540.9例/月、均方根误差659.4,均优于基线ARIMA模型的9.0%、704.9例/月、1075.8,并检测到COVID-19疫情初期药物过量死亡的突然增加。作者认为聚合尿液药物检测数据或可用于估算最新药物过量死亡趋势。

要点

  • 美国药物过量死亡临时估算滞后6个月,本研究评估聚合尿液药物检测数据填补该滞后窗口的效用。
  • 模型基于前4年数据训练负二项广义线性模型,用月度尿液药物检测数据估算滞后6个月窗口的全国药物过量死亡数。
  • 模型平均绝对百分比误差7.1%、平均绝对误差540.9例/月、均方根误差659.4,优于基线ARIMA模型的9.0%、704.9例/月、1075.8。
  • 模型检测到2020年初COVID-19疫情开始时药物过量死亡的突然增加。
  • 作者认为聚合尿液药物检测数据或可用于估算最新药物过量死亡趋势,模型可通过引入药物缴获和症候群监测等暴露变量改进。

适用人群与场景

  • 美国物质使用障碍治疗医疗机构中年龄18岁及以上、提交尿液药物检测的患者,2015年1月1日至2025年1月31日共3135748份样本(57.2%来自男性,平均[SD]年龄38.1[12.4]岁)。

研究设计与关键结果

  • 研究类型为横断面研究,纳入3135748份尿液药物检测样本,样本来自美国物质使用障碍治疗医疗机构。
  • 2019年至2024年8月,美国共有537104人死于药物过量,2020年初COVID-19疫情开始时出现大幅增加。
  • 尿液药物检测建模策略平均绝对百分比误差7.1%、平均绝对误差540.9例/月、均方根误差659.4,优于基线自回归积分滑动平均模型的9.0%、704.9例/月、1075.8,所有指标均更优。
  • 模型检测到COVID-19疫情开始时药物过量死亡的突然增加。

证据类型、等级与局限

  • 证据类型为横断面研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,聚合尿液药物检测数据或可用于估算最新药物过量死亡趋势。
  • 作者认为,模型实施可通过引入药物缴获和症候群监测等相关额外暴露变量改进。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Provisional estimates of fatal drug overdoses in the US are lagging by 6 months. Efforts to estimate the overdose burden for this 6-month lag window require up-to-date data, such as real-time urine drug test (UDT) data, capable of identifying sudden changes in the overdose trajectory, such as the increase in overdose deaths experienced at the beginning of the COVID-19 pandemic.

OBJECTIVE: To evaluate the utility of using aggregated UDT data to estimate national-level drug overdose deaths for the 6-month lag window in which overdose data are unavailable.

DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study included 3 135 748 urine samples submitted for UDT by Millennium Health from patients aged 18 years or older in substance use disorder treatment health care facilities across the US between January 1, 2015, and January 31, 2025. Urine drug test results were aggregated to generate monthly positivity rates and mean creatinine-normalized levels of fentanyl and methamphetamine (among the sample testing positive for fentanyl). Monthly, national drug overdose mortality counts were obtained from the Centers for Disease Control and Prevention.

EXPOSURES: Urine drug testing.

MAIN OUTCOMES AND MEASURES: Drug overdose death totals were estimated for every 6-month period from January to June 2019 through August 2024 to January 2025 by training generalized linear models with a negative binomial distribution on the preceding 4 years of data and using monthly UDT data to generate overdose estimates for the 6-month lag window of interest. Mean absolute error (MAE), mean absolute percentage error (MAPE), and root mean squared error (RMSE) were calculated by comparing projected monthly estimates with observed overdose death totals.

RESULTS: A total of 3 135 748 UDT specimens (57.2% from men; mean [SD] age, 38.1 [12.4] years) were included in this study. From 2019 to August 2024, 537 104 people died of an overdose in the US, with a substantial increase in early 2020 at the onset of the COVID-19 pandemic. The UDT modeling strategy (MAPE, 7.1%; MAE, 540.9 deaths per month; RMSE, 659.4) outperformed the baseline autoregressive integrated moving average model (MAPE, 9.0%; MAE, 704.9 deaths per month; RMSE, 1075.8) across all metrics. Furthermore, the model detected the sudden increase in overdose deaths at the start of the COVID-19 pandemic.

CONCLUSIONS AND RELEVANCE: In this cross-sectional study, findings suggested that aggregated UDT data may be used to estimate up-to-date overdose death trends. Model implementation can be improved by introducing additional exposure variables, such as those related to drug seizures and syndromic surveillance.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Myers JV, Marks C, Kim J, et al. Generating Timely Estimates of Overdose Deaths for the US Using Urine Drug Test Data. JAMA Netw Open. 2025. PMID: 40489110. doi:10.1001/jamanetworkopen.2025.14402

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。